💊📈 Check out our latest #pharmacoepi study on the Risk of Intraocular Pressure Increase With #Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors published on American Journal of Ophthalmology. The results of our study are suggestive of an increased risk of #IOP increase in non-diabetic patients using #bevacizumab and #ranibizumab compared with #aflibercept users

#AntiVEGF #eye #pharmacoepidemiology

https://www.sciencedirect.com/science/article/abs/pii/S0002939422004408

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) 2023: Abstract Submission Site Is Now Open. Abstract Submission Deadline: February 13, 2023. #epiverse #pharmacoepidemiology

https://www.abstractscorecard.com/cfp/submit/loginSSO.asp?EventKey=PHXMCKFX

Artificial intelligence in #pharmacovigilance: A regulatory perspective on explainability - Pinheiro - 2022 - #Pharmacoepidemiology and Drug Safety - Wiley Online Library

https://onlinelibrary.wiley.com/doi/full/10.1002/pds.5524?campaign=woletoc

Artificial intelligence in #pharmacovigilance: A regulatory perspective on explainability - Pinheiro - 2022 - #Pharmacoepidemiology and Drug Safety - Wiley Online Library

https://onlinelibrary.wiley.com/doi/full/10.1002/pds.5524?campaign=woletoc

Key biases arising in pharmacoepidemiologic studies
https://onlinelibrary.wiley.com/doi/10.1002/pds.5547

Case studies of biases best assessed with respect to the study population (including confounding by indication, channeling bias, healthy user bias, and protopathic bias), the study design (including prevalent user bias and immortal time bias), and the data source (including misclassification bias and missing data/loss to follow up).

#pharmacoepidemiology #bias #ebm #safety #harms

An overview of propensity score matching methods for clustered data - Benjamin Langworthy, Yujie Wu, Molin Wang, 2022

https://journals.sagepub.com/doi/abs/10.1177/09622802221133556 #Pharmacoepidemiology #biostatistics

An overview of propensity score matching methods for clustered data - Benjamin Langworthy, Yujie Wu, Molin Wang, 2022

https://journals.sagepub.com/doi/abs/10.1177/09622802221133556 #Pharmacoepidemiology #biostatistics

A latent class model to multiply impute missing treatment indicators in observational studies when inferences of the treatment effect are made using propensity score matching - Mitra - Biometrical Journal - Wiley Online Library

https://onlinelibrary.wiley.com/doi/full/10.1002/bimj.202100284?campaign=wolearlyview #pharmacoepidemiology #biostatistics

A latent class model to multiply impute missing treatment indicators in observational studies when inferences of the treatment effect are made using propensity score matching - Mitra - Biometrical Journal - Wiley Online Library

https://onlinelibrary.wiley.com/doi/full/10.1002/bimj.202100284?campaign=wolearlyview #pharmacoepidemiology #biostatistics

If you’re interested in what I do: Join #Sentinel Initiative Principal Investigator @DarrenToh_epi@twitter.com and members of the #USFDA at 3:40PM EST today for the Sentinel System Operations and Coordinating Center Perspectives session during the Annual Sentinel Initiative Workshop. #PublicHealth #Pharmacoepidemiology http://tinyurl.com/sentinelpublicmeeting

Hello #MedMastodon,

I'd like to start off with an #introduction 👋 .

I'm an Early Career Scholar-Pharmacist involved in research that focuses on knowledge mobilization and pharmacoepidemiology. My areas of interest are #AntimicrobialStewardship and integration of a sex and gender based analyses (#SGBA) into therapeutics research. I'm interested in co-designed interventions that improve patient-care.

Nice to meet y'all!

#TwitterMigration
#IDMastodon
#Epidemiology
#Pharmacoepidemiology

Hello #rheumatology #pharmacoepidemiology #epidemiology #biostatistics communities
#introduction I am a rheumatologist by clinical training, pharmacoepidemiologist by academic training. I work at a health care data/analytics company as a medical director and am involved in data product development and research projects in rheumatology/immunology.

Hello #rheumatology #pharmacoepidemiology #epidemiology #biostatistics communities
#introduction I am a rheumatologist by clinical training, pharmacoepidemiologist by academic training. I work at a health care data/analytics company as a medical director and am involved in data product development and research projects in rheumatology/immunology.

Hello mastodon #Pharmacoepidemiology !

Hello mastodon #Pharmacoepidemiology !